S100A8 and S100A9 in Human Arterial Wall
Michelle M. McCormick,Farid Rahimi,Yuri V. Bobryshev,Katharina Gaus,Hala Zreiqat,Hong Cai,Reginald S. A. Lord,Carolyn L. Geczy
DOI: https://doi.org/10.1074/jbc.m509442200
IF: 5.485
2005-01-01
Journal of Biological Chemistry
Abstract:Atherogenesis is a complex process involving inflammation. S100A8 and S100A9, the Ca2+-binding neutrophil cytosolic proteins, are associated with innate immunity and regulate processes leading to leukocyte adhesion and transmigration. In neutrophils and monocytes the S100A8-S100A9 complex regulates phosphorylation, NADPH-oxidase activity, and fatty acid transport. The proteins have anti-microbial properties, and S100A8 may play a role in oxidant defense in inflammation. Murine S100A8 is regulated by inflammatory mediators and recruits macrophages with a proatherogenic phenotype. S100A9 but not S100A8 was found in macrophages in ApoE-/- murine atherosclerotic lesions, whereas both proteins are expressed in human giant cell arteritis. Here we demonstrate S100A8 and S100A9 protein and mRNA in macrophages, foam cells, and neovessels in human atheroma. Monomeric and complexed forms were detected in plaque extracts. S100A9 was strongly expressed in calcifying areas and the surrounding extracellular matrix. Vascular matrix vesicles contain high levels of Ca2+-binding proteins and phospholipids that regulate calcification. Matrix vesicles characterized by electron microscopy, x-ray microanalysis, nucleoside triphosphate pyrophosphohydrolase assay and cholesterol/phospholipid analysis contained predominantly S100A9. We propose that S100A9 associated with lipid structures in matrix vesicles may influence phospholipid-Ca2+ binding properties to promote dystrophic calcification. S100A8 and S100A9 were more sensitive to hypochlorite oxidation than albumin or low density lipoprotein and immunoaffinity confirmed S100A8-S100A9 complexes; some were resistant to reduction, suggesting that hypochlorite may contribute to protein cross-linking. S100A8 and S100A9 in atherosclerotic plaque and calcifying matrix vesicles may significantly influence redox- and Ca2+-dependent processes during atherogenesis and its chronic complications, particularly dystrophic calcification. Atherogenesis is a complex process involving inflammation. S100A8 and S100A9, the Ca2+-binding neutrophil cytosolic proteins, are associated with innate immunity and regulate processes leading to leukocyte adhesion and transmigration. In neutrophils and monocytes the S100A8-S100A9 complex regulates phosphorylation, NADPH-oxidase activity, and fatty acid transport. The proteins have anti-microbial properties, and S100A8 may play a role in oxidant defense in inflammation. Murine S100A8 is regulated by inflammatory mediators and recruits macrophages with a proatherogenic phenotype. S100A9 but not S100A8 was found in macrophages in ApoE-/- murine atherosclerotic lesions, whereas both proteins are expressed in human giant cell arteritis. Here we demonstrate S100A8 and S100A9 protein and mRNA in macrophages, foam cells, and neovessels in human atheroma. Monomeric and complexed forms were detected in plaque extracts. S100A9 was strongly expressed in calcifying areas and the surrounding extracellular matrix. Vascular matrix vesicles contain high levels of Ca2+-binding proteins and phospholipids that regulate calcification. Matrix vesicles characterized by electron microscopy, x-ray microanalysis, nucleoside triphosphate pyrophosphohydrolase assay and cholesterol/phospholipid analysis contained predominantly S100A9. We propose that S100A9 associated with lipid structures in matrix vesicles may influence phospholipid-Ca2+ binding properties to promote dystrophic calcification. S100A8 and S100A9 were more sensitive to hypochlorite oxidation than albumin or low density lipoprotein and immunoaffinity confirmed S100A8-S100A9 complexes; some were resistant to reduction, suggesting that hypochlorite may contribute to protein cross-linking. S100A8 and S100A9 in atherosclerotic plaque and calcifying matrix vesicles may significantly influence redox- and Ca2+-dependent processes during atherogenesis and its chronic complications, particularly dystrophic calcification. Atherosclerosis is a progressive chronic disease for which the prevailing “response-to-injury” hypothesis emphasizes endothelial dysfunction and accommodates the various risk factors, underscoring the importance of the immune system and chronic inflammation in its initiation, progression, and complications. Advanced atherosclerosis is often associated with dystrophic calcification, and there is a relationship between calcification and the severity of coronary disease. Dystrophic calcification results in less compliant and more rupture-prone vessels, precipitating ischemic and thrombotic complications. Initiation of calcification occurs within matrix vesicles (MVs) 4The abbreviations used are: MVsmatrix vesiclesPSphosphatidylserineMGPmatrix Gla proteinmS100A8murine S100A8LDLlow-density lipoproteinFCfoam cellECendothelial cellsMPOmyeloperoxidaserrecombinantOxS100A8HOCl-oxidized S100A8DCdendritic cellPBSphosphate-buffered salineNEMN-ethylmaleimideTBSTris-buffered salineTEMtransmission electron microscopySEMscanning electron microscopyNTPPPHnucleoside triphosphate pyrophosphohydrolaseECMextracellular matrixDTTdithiothreitolELISAenzyme-linked immunosorbent assay.4The abbreviations used are: MVsmatrix vesiclesPSphosphatidylserineMGPmatrix Gla proteinmS100A8murine S100A8LDLlow-density lipoproteinFCfoam cellECendothelial cellsMPOmyeloperoxidaserrecombinantOxS100A8HOCl-oxidized S100A8DCdendritic cellPBSphosphate-buffered salineNEMN-ethylmaleimideTBSTris-buffered salineTEMtransmission electron microscopySEMscanning electron microscopyNTPPPHnucleoside triphosphate pyrophosphohydrolaseECMextracellular matrixDTTdithiothreitolELISAenzyme-linked immunosorbent assay. (1Bonucci E. J. Ultrastruct. Res. 1967; 20: 33-50Crossref PubMed Scopus (474) Google Scholar), extracellular microstructures originating from budding of plasma membranes (2Wu L.N. Genge B.R. Dunkelberger D.G. LeGeros R.Z. Concannon B. Wuthier R.E. J. Biol. Chem. 1997; 272: 4404-4411Abstract Full Text Full Text PDF PubMed Scopus (114) Google Scholar). Calcifying MVs contain high levels of Ca2+ binding acidic phospholipids, particularly phosphatidylserine (PS) (2Wu L.N. Genge B.R. Dunkelberger D.G. LeGeros R.Z. Concannon B. Wuthier R.E. J. Biol. Chem. 1997; 272: 4404-4411Abstract Full Text Full Text PDF PubMed Scopus (114) Google Scholar) and membrane phosphatases, which hydrolyze a variety of naturally occurring organic phosphoesters (3Hsu H.H. J. Biol. Chem. 1983; 258: 3463-3468Abstract Full Text PDF PubMed Google Scholar, 4Siegel S.A. Hummel C.F. Carty R.P. J. Biol. Chem. 1983; 258: 8601-8607Abstract Full Text PDF PubMed Google Scholar) ultimately forming nascent calcium phosphate mineral. The membrane-invested internal microenvironment protects the precurrent mineral nuclei in a pre-crystalline state, before conversion to hydroxyapatite (5Anderson H.C. Lab. Investig. 1989; 60: 320-330PubMed Google Scholar). The presence of bone morphogenic proteins and non-collagenous bone matrix proteins including osteopontin, osteonectin, and matrix Gla protein (MGP) in atherosclerotic lesions indicates that vascular calcification is actively regulated (6Canfield A.E. Farrington C. Dziobon M.D. Boot-Handford R.P. Heagerty A.M. Kumar S.N. Roberts I.S. J. Pathol. 2002; 196: 228-234Crossref PubMed Scopus (105) Google Scholar, 7Dhore C.R. Cleutjens J.P. Lutgens E. Cleutjens K.B. Geusens P.P. Kitslaar P.J. Tordoir J.H. Spronk H.M. Vermeer C. Daemen M.J. Arterioscler. Thromb. Vasc. Biol. 2001; 21: 1998-2003Crossref PubMed Scopus (601) Google Scholar), although mechanisms are unclear.Inflammation-associated “calgranulins,” S100A8 (MRP-8) and S100A9 (MRP-14), members of the S100 family of Ca2+-binding proteins (8Ravasi T. Hsu K. Goyette J. Schroder K. Yang Z. Rahimi F. Miranda L.P. Alewood P.F. Hume D.A. Geczy C. Genomics. 2004; 84: 10-22Crossref PubMed Scopus (125) Google Scholar), are highly expressed in numerous inflammatory conditions, including giant cell arteritis (9Foell D. Hernandez-Rodriguez J. Sanchez M. Vogl T. Cid M.C. Roth J. J. Pathol. 2004; 204: 311-316Crossref PubMed Scopus (75) Google Scholar), cystic fibrosis, rheumatoid arthritis, dermatoses, some malignancies, and autoimmune diseases (10Nacken W. Roth J. Sorg C. Kerkhoff C. Microsc. Res. Tech. 2003; 60: 569-580Crossref PubMed Scopus (278) Google Scholar, 11Foell D. Frosch M. Sorg C. Roth J. Clin. Chim. Acta. 2004; 344: 37-51Crossref PubMed Scopus (254) Google Scholar). They are major cytosolic proteins in neutrophils and monocytes and found in subsets of macrophages at chronic inflammatory sites, but not in tissue macrophages (10Nacken W. Roth J. Sorg C. Kerkhoff C. Microsc. Res. Tech. 2003; 60: 569-580Crossref PubMed Scopus (278) Google Scholar, 11Foell D. Frosch M. Sorg C. Roth J. Clin. Chim. Acta. 2004; 344: 37-51Crossref PubMed Scopus (254) Google Scholar). Monocytes infiltrating early atherosclerotic lesions, and macrophages within mature plaque of ApoE-/- mice were reported as S100A9+-S100A8- (12Eue I. Langer C. Eckardstein A. Sorg C. Atherosclerosis. 2000; 151: 593-597Abstract Full Text Full Text PDF PubMed Scopus (25) Google Scholar). Intracellular S100A8 and S100A9 essentially regulate phagocyte migration through calcium and mitogen-activated protein kinase (MAPK) transduction pathways affecting the microtubular system (13Vogl T. Ludwig S. Goebeler M. Strey A. Thorey I.S. Reichelt R. Foell D. Gerke V. Manitz M.P. Nacken W. Werner S. Sorg C. Roth J. Blood. 2004; 104: 4260-4268Crossref PubMed Scopus (244) Google Scholar). Murine (m) S100A8 is a potent leukocyte chemoattractant (14Lackmann M. Rajasekariah P. Iismaa S.E. Jones G. Cornish C.J. Hu S. Simpson R.J. Moritz R.L. Geczy C.L. J. Immunol. 1993; 150: 2981-2991PubMed Google Scholar); mS100A8-elicited macrophages exhibit a “pro-atherogenic phenotype,” expressing high levels of CD11b/CD18, Fc and scavenger receptors that accumulate acetylated low density lipoprotein (LDL) in vitro and in vivo, with cholesterol-ester profiles similar to those in human plaque and thus may contribute to potential foam cell (FC) development (15Lau W. Devery J.M. Geczy C.L. J. Clin. Investig. 1995; 95: 1957-1965Crossref PubMed Scopus (56) Google Scholar). Extracellularly, the S100A8-S100A9 complex (known as calprotectin) exerts antimicrobial activity (10Nacken W. Roth J. Sorg C. Kerkhoff C. Microsc. Res. Tech. 2003; 60: 569-580Crossref PubMed Scopus (278) Google Scholar), stimulates IL-8 production by airway epithelial cells (16Ahmad A. Bayley D.L. He S. Stockley R.A. Am. J. Respir. Cell Mol. Biol. 2003; 29: 523-530Crossref PubMed Scopus (38) Google Scholar), and transports arachidonic acid to endothelial cell (EC) targets affecting pathological responses in inflammation and atherosclerosis (10Nacken W. Roth J. Sorg C. Kerkhoff C. Microsc. Res. Tech. 2003; 60: 569-580Crossref PubMed Scopus (278) Google Scholar).S100A8 is secreted by appropriately activated macrophages (10Nacken W. Roth J. Sorg C. Kerkhoff C. Microsc. Res. Tech. 2003; 60: 569-580Crossref PubMed Scopus (278) Google Scholar) and is exquisitely sensitive to oxidation, particularly by peroxide and hypochlorite (HOCl/OCl-) (17Raftery M.J. Yang Z. Valenzuela S.M. Geczy C.L. J. Biol. Chem. 2001; 276: 33393-33401Abstract Full Text Full Text PDF PubMed Scopus (113) Google Scholar), and a role in antioxidant defense is proposed (18Harrison C.A. Raftery M.J. Walsh J. Alewood P. Iismaa S.E. Thliveris S. Geczy C.L. J. Biol. Chem. 1999; 274: 8561-8569Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). HOCl from activated leukocytes generates inter-/intramolecular covalent cysteine-lysine sulfinamide bonds in S100A8 (17Raftery M.J. Yang Z. Valenzuela S.M. Geczy C.L. J. Biol. Chem. 2001; 276: 33393-33401Abstract Full Text Full Text PDF PubMed Scopus (113) Google Scholar). HOCl is generated by myeloperoxidase (MPO), which co-localizes with macrophages (19Sugiyama S. Okada Y. Sukhova G.K. Virmani R. Heinecke J.W. Libby P. Am. J. Pathol. 2001; 158: 879-891Abstract Full Text Full Text PDF PubMed Scopus (600) Google Scholar) in human plaque where it oxidizes LDL to a proatherogenic form (20Hazell L.J. Arnold L. Flowers D. Waeg G. Malle E. Stocker R. J. Clin. Investig. 1996; 97: 1535-1544Crossref PubMed Scopus (530) Google Scholar) and may also regulate proteases contributing to plaque rupture (21Heinecke J.W. Am. J. Cardiol. 2003; 91 (A): 12A-116Abstract Full Text Full Text PDF PubMed Scopus (161) Google Scholar). Other S100s, such as S100A2 (22Zhang T. Woods T.L. Elder J.T. J. Invest. Dermatol. 2002; 119: 1196-1201Abstract Full Text Full Text PDF PubMed Scopus (39) Google Scholar), are also implicated in cell responses to oxidative stress and S100B and S100A1 may link Ca2+- and redox-mediated signaling pathways, possibly by Ca2+-modulated S100 cysteine thiol-glutathione covalent interactions (23Goch G. Vdovenko S. Kozlowska H. Bierzynski A. Febs. J. 2005; 272: 2557-2565Crossref PubMed Scopus (44) Google Scholar, 24Zhukova L. Zhukov I. Bal W. Wyslouch-Cieszynska A. Biochim. Biophys. Acta. 2004; 1742: 191-201Crossref PubMed Scopus (50) Google Scholar). Intracellularly, the S100A8-S100A9 complex forms a scaffold for NADPH-oxidase components (10Nacken W. Roth J. Sorg C. Kerkhoff C. Microsc. Res. Tech. 2003; 60: 569-580Crossref PubMed Scopus (278) Google Scholar) and regulates casein kinase activity (25Tugizov S. Berline J. Herrera R. Penaranda M.E. Nakagawa M. Palefsky J. J. Virol. 2005; 79: 1099-1112Crossref PubMed Scopus (56) Google Scholar).This is the first report of calgranulins in macrophages and FC in human atheroma and in areas of vascular calcification. S100A8 and S100A9 mRNA and protein were also expressed by microvessels in areas of neovascularization. Monomeric and complexed forms of S100A9 were predominant in MVs isolated from human carotid artery and aorta suggesting a role in regulation of dystrophic calcification. We show high amounts of S100A8 and S100A9 complexes in plaque extracts and demonstrate the exquisite sensitivity, particularly of S100A8, to oxidation by HOCl, strongly suggesting it as a ready target for oxidation in vivo.MATERIALS AND METHODSProteins and Antibodies—Recombinant (r) S100A8 and rS100A9 were generated as described (26Iismaa S.E. Hu S. Kocher M. Lackmann M. Harrison C.A. Thliveris S. Geczy C.L. DNA Cell Biol. 1994; 13: 183-192Crossref PubMed Scopus (34) Google Scholar). The monoclonal antibody against HOCl-modified LDL (HOP-1) (20Hazell L.J. Arnold L. Flowers D. Waeg G. Malle E. Stocker R. J. Clin. Investig. 1996; 97: 1535-1544Crossref PubMed Scopus (530) Google Scholar) was a gift from Dr. R. Stocker. Rabbit IgGs against S100A8, HOCl-oxidized S100A8 (OxS100A8) (17Raftery M.J. Yang Z. Valenzuela S.M. Geczy C.L. J. Biol. Chem. 2001; 276: 33393-33401Abstract Full Text Full Text PDF PubMed Scopus (113) Google Scholar) or S100A9 were raised and purified as described (26Iismaa S.E. Hu S. Kocher M. Lackmann M. Harrison C.A. Thliveris S. Geczy C.L. DNA Cell Biol. 1994; 13: 183-192Crossref PubMed Scopus (34) Google Scholar). Preimmune IgGs were unreactive in Western blotting/immunohistochemistry. S100 proteins share regions of high sequence homology and cross-reactivities of antibodies were tested by Western blotting. Anti-S100A1/B (Dako Carpintaria, CA) recognized S100A1 and S100B (Sigma) but not the other S100 proteins; anti-S100A8, -OxS100A8, and -S100A9 were immunospecific. Anti-OxS100A8 reacted more strongly with OxS100A8 than S100A8 by ELISA (27Kocher M. Kenny P.A. Farram E. Majid Abdul Finlay-Jones K.B. Geczy J.J.C.L. Infect. Immun. 1996; 64: 1342-1350Crossref PubMed Google Scholar).Carotid and Aortic Specimens—Aortic and carotid artery specimens containing atherosclerotic lesions and apparently normal mural areas, collected according to the Declaration of Helsinki, were obtained from 39 patients undergoing endarterectomy and 14 (aged 32-86 years) undergoing aortic reconstruction, respectively, at St Vincent's and Concord General Repatriation Hospitals, Sydney.Immunohistochemical Analysis—For immunohistochemistry, 11 carotid and 9 aortic specimens were used. Tissue processing and single and double immunostaining were performed as reported (28Bobryshev Y.V. Lord R.S. Cardiovasc. Res. 1998; 37: 799-810Crossref PubMed Scopus (224) Google Scholar). Optimal antibody concentrations were determined by calibrating staining intensities in various tissues. Anti-S100A1/S100B, -S100A9, or -S100A8 IgGs were used at 6.4, 1, and 2 μg/ml, respectively. Anti-CD3 (T-cell marker; Sigma), anti-CD68 (monocyte/macrophage marker), anti-von-Will-ebrand factor (EC marker), and fascin (dendritic cell (DC) marker, all from Dako) were used at 1:50 dilution and anti-α-smooth muscle actin (Dako) at 1:400 v/v. Secondary antibodies were biotinylated equine anti-mouse, caprine anti-rabbit, and rabbit anti-caprine (Vector Laboratories, Burlingame, CA) IgGs. For negative controls, primary antibodies were omitted, or sections treated with pre-/nonimmune rabbit IgG. Control sections were negative. Immunostaining in sections stained with Alizarin red S, which identifies atherosclerotic calcification, was difficult, so calcified deposits were visualized by counterstaining with Mayer's hematoxylin.In Situ Hybridization—Tissue sections were washed (15 min) in phosphate-buffered saline (PBS, 25 mm PO43−, 250 mm Cl-, pH 7.5) containing Triton X-100 (0.3%), treated with 0.2 m HCl (15 min), permeabilized with proteinase K (25 μg/ml, MERCK; Darmstadt, Germany) in 0.1 m Tris-HCl/50 mm EDTA, pH 8.0 (37 °C, 30 min), washed with 0.2% glycine followed by PBS, and post-fixed with 4% paraformaldehyde in PBS (5 min). Photobiotin-labeled cDNA as whole plasmids (vector and insert; 100 μl/slide) were used for hybridization. Stringency washes and detection were performed according to a sensitive method (29Markovic B. Kwan Y.L. Nicholls E.M. Walsh C. Crouch R.L. J. Pathol. 1992; 167: 369-373Crossref PubMed Scopus (12) Google Scholar), with biotinylated alkaline phosphatase and streptavidin (both from Sigma) at 1:200 and 1:100 v/v, respectively, during four sequential 10-min applications for detection. S100A8 (360 bp) and S100A9 (413 bp) full-length cDNAs were synthesized from human neutrophil RNA and subcloned at BamHI-EcoRI and EcoRI-HindIII sites of pGEM-3Z vector (Promega). Integration was confirmed using restriction enzyme digestion. Vector alone, or unrelated plasmid vectors were used as negative controls; hybridizations with these were negative. Detection of GAPDH mRNA was the internal positive control.Arterial Tissue Extraction—Specimens from 11 endarterectomy patients were pulverized under liquid nitrogen. Samples of apparently normal carotid artery (taken from a 74-year-old male who died of chronic obstructive pulmonary disease; 25-h post-mortem delay) were similarly processed and because of the low protein content, pooled extracts from two different mural sections analyzed. Samples (∼500 mg) in PBS/10 mm EGTA (1.5 ml, pH 7.5) containing protease inhibitor mixture (Roche Applied Science, Mannheim, Germany) were sonicated for 5 min, rotated at 4 °C for 2 h then centrifuged (1,600 × g, 20 min, 4 °C). Supernatants were precleared with caprine anti-rabbit IgG (∼1 μg/ml, 1 h at 4°C) and protein A-Sepharose (∼25 μl/500 μl, 15 min, 4 °C) or agarose-conjugated caprine anti-rabbit IgG (Sigma), centrifuged and ∼25-30 μg of total protein (bicinchoninic acid assay, Sigma) used for analysis. Because of the propensity of S100 proteins to form disulfide (30Deshpande R. Woods T.L. Fu J. Zhang T. Stoll S.W. Elder J.T. J. Investig. Dermatol. 2000; 115: 477-485Abstract Full Text Full Text PDF PubMed Scopus (44) Google Scholar) and sulfinamide cross-linking (17Raftery M.J. Yang Z. Valenzuela S.M. Geczy C.L. J. Biol. Chem. 2001; 276: 33393-33401Abstract Full Text Full Text PDF PubMed Scopus (113) Google Scholar) under oxidative conditions, five additional endarterectomy specimens were prepared in PBS containing 1 mm sodium azide (inhibits MPO that generates HOCl) (31Panasenko O.M. Spalteholz H. Schiller J. Arnhold J. Free Radic. Biol. Med. 2003; 34: 553-562Crossref PubMed Scopus (63) Google Scholar) and 10 mm N-ethylmaleimide (NEM; derivatizes free thiols) (18Harrison C.A. Raftery M.J. Walsh J. Alewood P. Iismaa S.E. Thliveris S. Geczy C.L. J. Biol. Chem. 1999; 274: 8561-8569Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar).Isolation and Characterization of Calcifying Vesicles—MVs from 12 carotid and 5 aortic specimens were isolated as described (32Hsu H.H. Camacho N.P. Atherosclerosis. 1999; 143: 353-362Abstract Full Text Full Text PDF PubMed Scopus (81) Google Scholar). All buffers contained protease inhibitors (Roche Applied Science), 10 mm EGTA, 10 mm NEM, 1 mm azide, and 1 mm benzamidine (Sigma). Specimens (∼1 × 2 cm2-1 × 4 cm2, ∼0.5 g-1.5 g) were preserved in 1% methyl cellulose and 1.15 m sucrose for 1 h at 4°C, subsequently frozen in liquid nitrogen and transferred to -80 °C before extraction. The MV pellets were dissolved in 1 ml of Tris-buffered saline (25 mm Tris/250 mm Cl-; TBS) and precleared as above prior to Western analysis.The procedure for transmission electron microscopy (TEM) was adapted from a previous study (33Bobryshev Y.V. Lord R.S. Warren B.A. Atherosclerosis. 1995; 118: 9-21Abstract Full Text PDF PubMed Scopus (59) Google Scholar). To quantitate the calcium and phosphorous content of MVs, suspensions (25 μl) were dried at 22 °C for 2 h and then mounted onto carbon disks coated with Balzes carbon fiber. Element content was assessed using a Cambridge S-360 scanning electron microscope (SEM) with Iridium software. The SEM was equipped with an EDS detector (1XRF Kevex with beryllium window) and 1-5 nA of beam current at 20 kV were used to acquire x-ray data. To confirm pyrophosphohydrolase activity, the nucleoside triphosphate pyrophosphohydrolase (NTPPPH) assay was performed on duplicate samples as described (34Rachow J.W. Ryan L.M. McCarty D.J. Halverson P.C. Arthritis. Rheum. 1988; 31: 408-413Crossref PubMed Scopus (48) Google Scholar). Results are expressed as nmol of p-nitrophenol formed/min/mg MV protein. Protein concentrations were determined with the bicinchoninic acid assay.Extraction of cholesterol and lipids from isolated MVs was performed as described (35Bligh E.G. Dyer W.J. Can. J. Med. Sci. 1959; 37: 911-917Google Scholar). To determine the cholesterol content, membrane samples (1 ml) were mixed with methanol (2.5 ml) and extracted into hexane (5.0 ml) (36Gelissen I.C. Brown A.J. Mander E.L. Kritharides L. Dean R.T. Jessup W. J. Biol. Chem. 1996; 271: 17852-17860Abstract Full Text Full Text PDF PubMed Scopus (118) Google Scholar). Cholesterol was analyzed by reverse phase high performance liquid chromatography as described (37Brown A.J. Dean R.T. Jessup W. J. Lipid Res. 1996; 37: 320-335Abstract Full Text PDF PubMed Google Scholar) and phospholipid content by the Bartlett assay (38Sokoloff L. Rothblat G.H. Proc. Soc. Exp. Biol. Med. 1974; 146: 1166-1172Crossref PubMed Scopus (109) Google Scholar).Western Blotting and Immunoabsorption—SDS-PAGE (10% gels) was performed as described (26Iismaa S.E. Hu S. Kocher M. Lackmann M. Harrison C.A. Thliveris S. Geczy C.L. DNA Cell Biol. 1994; 13: 183-192Crossref PubMed Scopus (34) Google Scholar) using degassed buffers. Electroblotting (26Iismaa S.E. Hu S. Kocher M. Lackmann M. Harrison C.A. Thliveris S. Geczy C.L. DNA Cell Biol. 1994; 13: 183-192Crossref PubMed Scopus (34) Google Scholar) used ovalbumin (7%, w/v) as blocking agent and Tween 20 (0.05%) in TBS for washes. Immunoreactivity with anti-S100A8 (20 μg), -OxS100A8 (10 μg), or -S100A9 (7 μg) IgGs in 10 ml of 2% ovalbumin in TBS for 2 h, or with HOP-1 (myeloma supernatant, 1:300 v/v), was visualized by chemiluminescence.Carotid artery extracts, pooled (1 ml) from 4 subjects, were diluted with PBS (4 ml) and pumped through Sepharose-4B-bound anti-S100A9 IgG (2.7 mg IgG/ml beads) at 4 °C as described (27Kocher M. Kenny P.A. Farram E. Majid Abdul Finlay-Jones K.B. Geczy J.J.C.L. Infect. Immun. 1996; 64: 1342-1350Crossref PubMed Google Scholar). After washing (PBS), bound material was eluted with 6 × 200 μl 0.2 m glycine, 0.1 m NaCl, pH 2.0, eluates buffered to pH 7.0 with Tris-HCl (1 m, pH 9), desalted/concentrated (Microcon YM-3 minifilters, Millipore, Bedford, MA), precleared as for arterial tissue extracts, and examined by Western blotting.RESULTSS100B, S100A8, and S100A9 Expression in Plaque—Arteries lacking features of atherosclerotic transformation did not contain cells expressing S100A8 (Fig. 1A) or S100A9 (not shown) in the intima. Nerve endings in the adventitia were S100A1+/S100B+ in normal and diseased tissue, and some cells distributed irregularly throughout all layers of the arterial wall, and particularly frequent around neovessels, were S100A1-/S100B- and fascin-positive, identifying them as DC (28Bobryshev Y.V. Lord R.S. Cardiovasc. Res. 1998; 37: 799-810Crossref PubMed Scopus (224) Google Scholar) (not shown).All vessel segments affected by early- and late-stage atherosclerosis contained large numbers of irregularly distributed, intensely stained S100A8+ FC and macrophages (Fig. 1, B and C), some of which were S100A8+-CD68+ although the majority around neovessels were CD68+-S100A8-. About 50% of neovascular EC were S100A8+ (Fig. 1B). In intimal areas containing CD68+ macrophages, many FC were S100A8+ (Fig. 1C). S100A9+ was present in FC and non-FC, particularly CD68 macrophages around neovessels, and in EC of all neovessels. The surrounding extracellular matrix (ECM) exhibited relatively intense S100A9 immunoreactivity (Fig. 1D). In situ hybridization indicated S100A8 (not shown) and S100A9 mRNA in FC, extravasating monocytes around neovessels and microvessels in areas of neovascularization (Fig. 1E). S100A8 or S100A9 were not detected in the luminal endothelium of arteries or the larger vasa vasorum (not shown).Consecutive sections indicated no S100A8 or S100A9 expression in T lymphocytes or smooth muscle cells (not shown). Overlapping patterns of distribution of S100A8 and S100A9 were apparent in FC and non-FC (not shown), particularly CD68+ macrophages around neovessels.In particular, anti-S100A9 immunoreactivity was associated with early (Fig. 2A) and large advanced calcified deposits (Fig. 2, B-E) that were surrounded by S100A9+ cells, mainly macrophages (CD68+) and some FC, some of which were closely attached to calcified deposits (Fig. 2C). These deposits consistently contained S100A9 in the ECM (Fig. 2E). S100A9 associated with calcified deposits was evident in all 11 carotid and 9 aortic specimens examined. Serial sections of the same specimens stained with anti-S100A8 showed markedly less reactivity; some S100A8 was associated with calcified deposits in 4 carotid arteries and 2 aortas (not shown).FIGURE 2Co-localization of S100A9 (brown) with calcified deposits (violet) in early (A) and advanced (B-E) atherosclerotic plaques stained with anti-S100A9. A, S100A9 was localized intra- and extracellularly. Numerous S100A9+ cells showed ill-defined borders suggesting their destruction. B, low magnification micrograph showing S100A9+ cells located in an intimal area containing large calcified deposits. C and D show details of B. In Fig. 2C, some S100A9+ cells (arrows) are closely attached to calcified deposits (asterisk). E, S100A9+ cells exhibiting ill-defined contours (straight arrows) apposed with calcified deposits (asterisk); anti-S100A9 immunoreactivity is evident extracellularly (open arrow).View Large Image Figure ViewerDownload Hi-res image Download (PPT)Characterization of MV Isolates—TEM confirmed the heterogeneous structural appearance of MV isolates (Fig. 3, A-C). Size varied from 40-1,200 nm; some had electron-lucent content (Fig. 3A), whereas others were filled with material of middle electron density or contained an electron dense core (Fig. 3B). Some MVs were clustered (Fig. 3C), and the membrane was absent in the contact zones suggesting that MVs coalesced. NTPPPH activity in MV isolates from 8 carotid specimens (mean: 315 ± 173 nmol/min/mg protein) was similar to levels reported for human vascular MVs (32Hsu H.H. Camacho N.P. Atherosclerosis. 1999; 143: 353-362Abstract Full Text Full Text PDF PubMed Scopus (81) Google Scholar). The lipid composition of two MV isolates was analyzed. Total sterol was 762.8 ± 23.3 nmol/mg protein and total phospholipid 745.5 ± 141 nmol/mg protein (TABLE ONE). Cholesterol esters comprised ∼14% of total sterols. HPLC analysis indicated that cholesteryl dodecanoate was the major ester (∼79%); ∼9.5% was cholesteryl oleate, and ∼2.3% was cholesteryl arachidonate.FIGURE 3Characterization of MV isolates. A-C, TEM electron micrographs of MVs isolated from an atherosclerotic carotid artery indicate structural heterogeneity. Ultra-thin sections stained with uranyl acetate and lead citrate were examined with accelerating voltage of 75 kV. D, S.E. x-ray energy spectrum. MV suspension mounted on carbon disks coated with Balzes carbon fiber assessed at 20 kV for 120 s. Isolate contained a Ca-to-P ratio of 0.66:1.View Large Image Figure ViewerDownload Hi-res image Download (PPT)TABLE ONEMV lipid analysisSampleTotal sterol/mgCholesterol esters/mgCholesterol/mgPhospholipid/mgnmol lipid/mg protein1746.30118.16628.14845.162779.24100.22679.02645.83 Open table in a new tab The mineral composition of carotid MV isolates (Fig. 3D), assessed by energy-dispersive x-ray microanalysis and SEM, indicated a Ca-to-P ratio of 0.66:1. Lower levels of sodium, sulfur, and chlorine were also present. In